Clinical Observation of Immunotherapy Efficacy and Adverse Effects 
in Chinese Patients with Lung Squamous Cell Carcinoma

This study aimed to investigate the efficacy and toxicity of immunotherapy in patients with LUSC in Chinese population of real world. Methods A total of 185 LUSC patients underwent pathological diagnosis were involved from January 2018 to January 2022. Patients were divided into elderly group (age ≥70 years) and younger group (age0.05). Both combined group and immunology alone demonstrated prolonged mPFS in first-line compared with chemotherapy in elderly group. And combined group demonstrated significantly prolonged mPFS compared with chemotherapy in younger group (P
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research